Inventor · disambiguated record
Alyson J. Berliner
Also filed as: BERLINER ALYSON J
2 granted patents·5 pending applications·5 citations·filing 2018–2025
50Inventor score
Files withREGENERON PHARMA7
Top patents by PatentIndex Score
7 records- 0188US10973879B2Use of a VEGF antagonist to treat angiogenic eye disordersREGENERON PHARMA·Filed 2018·Granted Apr 13, 2021·5 cites·21 claims
- 0266US12280093B2Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative diabetic retinopathyREGENERON PHARMA·Filed 2021·Granted Apr 22, 2025·0 cites·33 claims
- 0361US2025268983A1Use of a VEGF Antagonist to Treat Angiogenic Eye DisordersREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0457US2025025531A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0555US2024024420A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0653US2023295266A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0752US2023302085A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alyson J. Berliner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →